Get the Stockscreener App
0.6928
0.41%
0.0028
After Hours:
.68
-0.0128
-1.85%
Dariohealth Corp Stock (DRIO) Forecast
The Dariohealth Corp (DRIO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.846, representing a +599.48% increase from the current price of $0.6928. The highest analyst price target is $4.6866, and the lowest is $5.0055.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DRIO Price Target
Average 5.2486
(+657.60% Upside)
Is Dariohealth Corp (DRIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.01 | Neutral |
| STOCH(9,6) | 67.87 | Neutral |
| STOCHRSI(14) | 76.58 | Neutral |
| MACD(12,26) | -0.0111 | Buy |
| ADX(14) | 39.43 | Buy |
| William %R | -35.37 | Neutral |
| CCI(14) | 43.76 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6735
Buy
|
0.6818
Buy
|
| MA20 |
0.6593
Buy
|
0.684
Buy
|
| MA50 |
0.7295
Sell
|
0.727
Sell
|
| MA100 |
0.8199
Sell
|
0.8085
Sell
|
| MA200 |
0.996
Sell
|
0.9952
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, DRIO could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on DRIO, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.01 indicates that DRIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 67.87 indicates that DRIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 76.58 indicates that DRIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 39.43 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 43.76 indicates that DRIO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term DRIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Dariohealth Corp financial reports and earnings history, Dariohealth Corp (DRIO) stock could reach $20.41 by 2030, $9.5387 by 2040 and $31.24 by 2050. See the projected annual prices until 2050 of the Dariohealth Corp stock below:
- Dariohealth Corp (DRIO) is expected to reach an average price of $4.3482 in 2035, with a high prediction of $4.3505 and a low estimate of $4.428. This indicates an $527.63% rise from the last recorded price of $0.6928.
- Dariohealth Corp (DRIO) stock is projected to chart a bullish course in 2040, with an average price target of $9.7587, representing an $1,309% surge from its current level. The forecast ranges from a conservative $9.7629 to a sky-high $9.5387.
- Our analysts predict Dariohealth Corp (DRIO) to jump 2,616% by 2045, soaring from $19.55 to an average price of $18.82, potentially reaching $20.11. While $19.55 is the low estimate, the potential upside is significant.
- Dariohealth Corp (DRIO) stock is expected to climb by 2050, reaching an average of $31.01, a $4,376% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.24 and $31.52, respectively, highlighting the market's uncertainty.
Dariohealth Corp Stock (DRIO) Year by Year Forecast
Dariohealth Corp Stock (DRIO) Price Forecast for 2025
Dariohealth Corp Stock (DRIO) is expected to reach an average price of $5.4761 in 2025, with a high prediction of $10.37 and a low estimate of $0.5858. This indicates an +690.43% rise from the last recorded price of $0.6928.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $6.4415 | $5.0055 | $4.6866 | +829.77% |
| April, 2025 | $6.4613 | $6.6274 | $7.8494 | +832.63% |
| May, 2025 | $6.6852 | $7.1752 | $6.497 | +864.95% |
| June, 2025 | $5.729 | $5.7561 | $5.316 | +726.94% |
| July, 2025 | $5.9339 | $6.27 | $6.252 | +756.50% |
| August, 2025 | $5.5177 | $6.1177 | $6.1158 | +696.44% |
| September, 2025 | $5.0384 | $1.5908 | $6.6134 | +627.25% |
| October, 2025 | $3.7736 | $1.1874 | $10.37 | +444.69% |
| November, 2025 | $4.9997 | $2.6727 | $7.1116 | +621.67% |
| December, 2025 | $1.3651 | $0.5858 | $6.2687 | +97.04% |
Dariohealth Corp Stock (DRIO) Price Forecast for 2026
The predicted value for Dariohealth Corp (DRIO) in 2026 is set at an average of $10.64. Estimates vary from a peak of $21.15 to a trough of $0.1309, indicating an +1,436% surge from the present price of $0.6928.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.551 | $0.612 | $3.281 | +123.88% |
| February, 2026 | $2.6471 | $0.1309 | $3.0971 | +282.09% |
| March, 2026 | $6.9433 | $1.3852 | $9.6192 | +902.21% |
| April, 2026 | $17.30 | $7.1623 | $21.15 | +2,397% |
| May, 2026 | $9.2646 | $7.4965 | $19.77 | +1,237% |
| June, 2026 | $10.31 | $7.4407 | $16.19 | +1,388% |
| July, 2026 | $4.4559 | $3.7159 | $11.89 | +543.17% |
| August, 2026 | $9.872 | $4.0349 | $12.34 | +1,325% |
| September, 2026 | $8.9972 | $8.3972 | $14.03 | +1,199% |
| October, 2026 | $5.4133 | $4.4233 | $11.43 | +681.37% |
| November, 2026 | $4.2595 | $0.6914 | $5.6837 | +514.82% |
| December, 2026 | $4.6546 | $2.918 | $5.5359 | +571.86% |
Dariohealth Corp Stock (DRIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Dariohealth Corp (DRIO) is $5.3516, with a high forecast of $10.70 and a low forecast of $0.00432. This indicates an +672.46% increase from the last price of $0.6928.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.2008 | $3.5327 | $8.4708 | +939.37% |
| February, 2027 | $8.0169 | $6.4798 | $10.70 | +1,057% |
| March, 2027 | $5.1421 | $4.4321 | $8.2259 | +642.21% |
| April, 2027 | $2.1382 | $1.7682 | $5.5901 | +208.63% |
| May, 2027 | $0.4243 | $0.00432 | $2.1972 | -38.75% |
| June, 2027 | $0.4505 | $0.2534 | $1.4034 | -34.97% |
| July, 2027 | $1.6744 | $1.2915 | $1.0308 | +141.68% |
| August, 2027 | $1.7182 | $1.5553 | $1.3073 | +148.01% |
| September, 2027 | $0.2431 | $1.2381 | $1.7802 | -64.91% |
| October, 2027 | $1.4169 | $0.146 | $0.764 | +104.52% |
| November, 2027 | $0.0692 | $0.8808 | $1.1079 | -90.01% |
| December, 2027 | $0.7244 | $0.5256 | $0.8944 | +4.56% |
Dariohealth Corp Stock (DRIO) Price Forecast for 2028
In 2028, Dariohealth Corp (DRIO) is projected to reach an average price of $0.9367, with a high projection of $1.8374 and a low estimate of $0.036. This indicates an +35.21% rise from the last price of $0.6928.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.7895 | $1.4876 | $1.4395 | +158.30% |
| February, 2028 | $1.4134 | $2.0283 | $1.8374 | +104.01% |
| March, 2028 | $1.3682 | $1.3982 | $1.1971 | +97.49% |
| April, 2028 | $0.6421 | $0.9914 | $1.4401 | -7.32% |
| May, 2028 | $1.3669 | $0.754 | $1.0769 | +97.30% |
| June, 2028 | $0.6592 | $0.3892 | $1.6192 | -4.85% |
| July, 2028 | $0.5854 | $0.0963 | $0.9954 | -15.51% |
| August, 2028 | $0.7195 | $0.1244 | $0.7405 | +3.85% |
| September, 2028 | $0.7333 | $0.7323 | $0.4304 | +5.85% |
| October, 2028 | $0.5072 | $0.8143 | $0.7862 | -26.79% |
| November, 2028 | $0.072 | $0.212 | $0.1835 | -89.60% |
| December, 2028 | $0.1241 | $0.036 | $0.596 | -82.09% |
Dariohealth Corp Stock (DRIO) Price Forecast for 2029
The 2029 price forecast for Dariohealth Corp Stock (DRIO) is $6.5566 on average, with a high prediction of $13.10 and a low estimate of $0.00927. This represents an +846.40% increase from the previous price of $0.6928.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0893 | $0.00927 | $0.5212 | -87.11% |
| February, 2029 | $0.4046 | $0.1417 | $0.3446 | -41.60% |
| March, 2029 | $0.1785 | $0.2265 | $0.1556 | -74.24% |
| April, 2029 | $0.4223 | $0.0554 | $0.3396 | -39.04% |
| May, 2029 | $1.7372 | $0.6433 | $1.4482 | +150.74% |
| June, 2029 | $1.201 | $1.431 | $1.5281 | +73.36% |
| July, 2029 | $0.6949 | $0.7731 | $0.6299 | +0.30% |
| August, 2029 | $0.2797 | $0.2088 | $0.5774 | -59.62% |
| September, 2029 | $0.0564 | $0.0236 | $0.5774 | -91.86% |
| October, 2029 | $0.2784 | $0.0554 | $0.3354 | -59.81% |
| November, 2029 | $0.3723 | $0.2594 | $0.2624 | -46.26% |
| December, 2029 | $14.29 | $0.00941 | $13.10 | +1,963% |
Dariohealth Corp Stock (DRIO) Price Forecast for 2030
Dariohealth Corp Stock (DRIO) is expected to reach an average price of $20.50 in 2030, with a high forecast of $23.80 and a low forecast of $17.21. This signifies an +2,859% surge from the last price of $0.6928.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.05 | $17.21 | $20.41 | +3,083% |
| February, 2030 | $21.07 | $21.32 | $20.84 | +2,941% |
| March, 2030 | $18.83 | $19.23 | $21.28 | +2,618% |
| April, 2030 | $21.74 | $19.33 | $21.74 | +3,039% |
| May, 2030 | $23.27 | $22.36 | $22.75 | +3,259% |
| June, 2030 | $23.12 | $23.47 | $23.17 | +3,238% |
| July, 2030 | $24.33 | $24.16 | $23.76 | +3,411% |
| August, 2030 | $22.06 | $22.15 | $23.80 | +3,084% |
| September, 2030 | $20.67 | $21.74 | $21.49 | +2,883% |
| October, 2030 | $18.39 | $18.79 | $18.89 | +2,554% |
| November, 2030 | $20.79 | $18.55 | $18.97 | +2,900% |
| December, 2030 | $20.86 | $19.95 | $21.20 | +2,910% |
0.73%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):